Prospective Clinical Evaluation of a Novel Repositionable Plastic Stent for Endosonography‐Guided Hepaticogastrostomy With or Without Antegrade Stenting (With Videos)
Journal of Gastroenterology and Hepatology · 2026
DOI: 10.1111/jgh.70567 ↗Kurz gefasst
Video/Audio in der Zeitschrift Journal of Gastroenterology and Hepatology, 2026. Verfasst von Shuntaro Mukai und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan. Hauptthemen laut MEDLINE: Stents, Endosonography, Plastics, Gastrostomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background and study aims A repositionable plastic stent (PS), developed to overcome the limitations of conventional pusher‐type PS in endosonography‐guided hepaticogastrostomy (EUS‐HGS), minimizes the gap between the inner sheath and stent to improve insertability. This prospective single‐center study evaluated its feasibility, safety, and clinical effectiveness in malignant and benign biliary diseases. Patients and Methods Between August 2022 and August 2024, 100 consecutive patients undergoing EUS‐HGS using the repositionable PS were enrolled. Mechanical tract dilation was performed, and antegrade metal stenting was added when feasible.
Results
Trainees performed 76% of the procedures. The median bile duct diameter was 4.3 mm. Technical and functional success rates were 99% and 93.9%, respectively, without need for cautery dilation. Initial PS advancement failed in two benign cases with rigid bile ducts; the stent system was pulled back for additional dilation, enabling successful placement. Adverse events occurred in 10% of cases (biliary peritonitis, 6; cholangitis, 2; biloma from early stent bending, 1; bleeding, 1), all manageable, with intervention required in two cases. No stent migration occurred during the first month after insertion. Recurrent biliary obstruction developed in 24 cases, all with successful reintervention. Median time to recurrence of biliary obstruction was significantly longer for EUS‐HGS combined with antegrade stenting than for EUS‐HGS alone (389 vs. 168 days, p < 0.001).
Conclusions
This repositionable PS enables safe, effective EUS‐HGS using mechanical dilation alone and corrective pullback for difficult cases. Its controlled deployment and reliable reintervention support its usefulness in both malignant and benign biliary diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Tokyo Medical University, Tokyo, Japan.
ORCID-Profile: Takayoshi Tsuchiya, Yukitoshi Matsunami, Kazumasa Nagai, Hiroyuki Kojima, Kyoko Asano, Kento Shionoya
Zitieren
APA
Mukai, S., Sofuni, A., Tsuchiya, T., Tanaka, R., Tonozuka, R., Matsunami, Y., Nagai, K., Kojima, H., Minami, H., Hirakawa, N., Asano, K., Shionoya, K., & Itoi, T. (2026). Prospective Clinical Evaluation of a Novel Repositionable Plastic Stent for Endosonography‐Guided Hepaticogastrostomy With or Without Antegrade Stenting (With Videos). Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.70567
Vancouver
Mukai S, Sofuni A, Tsuchiya T, Tanaka R, Tonozuka R, Matsunami Y, et al. Prospective Clinical Evaluation of a Novel Repositionable Plastic Stent for Endosonography‐Guided Hepaticogastrostomy With or Without Antegrade Stenting (With Videos). Journal of Gastroenterology and Hepatology. 2026. doi:10.1111/jgh.70567
BibTeX
@article{Mukai2026,
author = {Mukai, Shuntaro and Sofuni, Atsushi and Tsuchiya, Takayoshi and Tanaka, Reina and Tonozuka, Ryosuke and Matsunami, Yukitoshi and Nagai, Kazumasa and Kojima, Hiroyuki and Minami, Hirohito and Hirakawa, Noriyuki and Asano, Kyoko and Shionoya, Kento and Itoi, Takao},
title = {Prospective Clinical Evaluation of a Novel Repositionable Plastic Stent for Endosonography‐Guided Hepaticogastrostomy With or Without Antegrade Stenting (With Videos)},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
doi = {10.1111/jgh.70567}
}
EUVIMED